Is Tirzepatide a Peptide? Prescription vs. Research Peptides

Is tirzepatide a peptide? Yes. Tirzepatide is a synthetic peptide: a chain of 39 amino acids built on the sequence of the gut hormone GIP, with a fatty acid chain attached so one dose lasts about a week. The FDA-approved Mounjaro label described it at approval in 2022 as "a 39-amino-acid modified peptide." Tirzepatide is the active ingredient in Eli Lilly's Mounjaro and Zepbound. Semaglutide, the active ingredient in Ozempic and Wegovy, is a peptide too. Being a peptide doesn't make a product safe or legal, though. As of October 2026, the FDA urges consumers not to buy tirzepatide sold "for research purposes" or "not for human consumption."

This guide explains what a peptide is, how tirzepatide is made, why it comes as an injection and not a pill, how semaglutide compares, and what the FDA says about "research peptides." It ends with the legal ways to get tirzepatide.

If you searched for a tirzepatide peptide because you want a lower price than the brand, there is a licensed route. Compounded tirzepatide is prepared by a licensed pharmacy for one patient's prescription and is not FDA-approved, which means the FDA hasn't reviewed it for safety, effectiveness or quality. Through MaxLife, an independent licensed provider decides whether it's right for you, and it costs $120 a month, flat. See how compounded tirzepatide works.

What Is a Peptide?

A peptide is a short chain of amino acids, the same building blocks that make up proteins. The difference is length. Under federal rules, "a protein is any alpha amino acid polymer with a specific, defined sequence that is greater than 40 amino acids in size" (21 CFR 600.3). A shorter chain is a peptide.

At 39 amino acids, tirzepatide sits just under that line. That matters for how it is regulated: peptides like tirzepatide are approved as drugs through a new drug application, while proteins are regulated as biological products. Mounjaro and Zepbound were both approved as new drugs.

Your body makes many peptides, and several of them are hormones. Two of them, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), are made in the intestine and help regulate appetite and blood sugar. In the FDA's words, Zepbound "works by activating receptors of hormones secreted from the intestine" to reduce appetite and food intake (FDA). Tirzepatide is a man-made peptide designed to act on the receptors for both hormones.

What Kind of Peptide Is Tirzepatide?

Tirzepatide is a modified peptide that activates two hormone receptors, GIP and GLP-1, which is why it is called a dual agonist. According to the Zepbound prescribing information (revised August 2026), its chain is based on the GIP sequence and has three kinds of changes:

• Two non-standard amino acids. Aminoisobutyric acid (Aib) sits at positions 2 and 13. The 2022 label calls them "non-coded" amino acids, meaning your body doesn't use them to build its own proteins.
• An amide cap at the end of the chain.
• A fatty acid. A 20-carbon fatty diacid is attached through a linker at position 20.

The fatty acid is what makes weekly dosing possible. The label says it "enables albumin binding and prolongs the half-life." Albumin is a protein in your blood, and about 99% of tirzepatide in the blood is bound to it. The half-life is about 5 to 6 days, so one injection a week keeps the medicine working.

The whole molecule is large for a medicine. Its molecular weight is 4,813.53 daltons, more than five times that of orforglipron, the active ingredient in the GLP-1 pill Foundayo (about 900 g/mol, from its label).

Is tirzepatide a hormone?

Not exactly. Tirzepatide is a medicine that imitates two natural hormones. The label says it "selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1." Your body doesn't make tirzepatide. It was designed in a lab to resist breakdown so that one dose lasts about a week.

How Is Tirzepatide Made?

Tirzepatide is made by chemical synthesis. It is not taken from animals or grown in cells. Eli Lilly scientists described the commercial process in a 2021 paper: tirzepatide is produced at kilogram scale using a hybrid of solid-phase and liquid-phase peptide synthesis, chemical methods that build the amino acid chain step by step (Organic Process Research & Development, 2021).

Semaglutide is made differently. The Wegovy label says "the peptide backbone is produced by yeast fermentation," and the molecule is then modified with a fatty acid chain.

Compounded tirzepatide starts with a bulk drug ingredient that a pharmacy buys and prepares for each patient's prescription. The FDA watches where those ingredients come from. On September 5, 2025, it created a "green list" import alert to stop GLP-1 active ingredients "from unverified foreign sources from entering the U.S. market." Ingredients from manufacturers that aren't on the list can be detained at the border.

Why Is Tirzepatide an Injection and Not a Pill?

Tirzepatide is an injection because it is a peptide, and peptides are absorbed poorly through the gut. Under the skin it works well: the label puts tirzepatide's bioavailability, the share of a dose that reaches the bloodstream, at 80% after a subcutaneous injection.

By mouth, peptides fare much worse. Semaglutide shows the problem clearly. Wegovy tablets contain an absorption enhancer called SNAC, must be taken on an empty stomach with no more than 4 ounces of water, and need a wait of at least 30 minutes before food or drink. Even then, only about 1% to 2% of the dose reaches the bloodstream, compared with 89% for the Wegovy injection. That is why the daily tablet goes up to 25 mg while the weekly injection is 2.4 mg (7.2 mg for the high-dose version). Our Wegovy pill vs injection guide compares the two forms.

As of November 2026, every FDA-approved tirzepatide product is an injection. Mounjaro was approved on May 13, 2022, and Zepbound on November 8, 2023, both as solutions injected under the skin in pens or vials. There is no FDA-approved tirzepatide pill. Our guide is there a tirzepatide pill? covers Foundayo and the oral products sold online.

The GLP-1 pill that avoids the absorption problem isn't a peptide. Foundayo (orforglipron), approved on April 1, 2026, is a small molecule taken once a day with or without food. It is a different medicine, not a form of tirzepatide.

If you're weighing the injectable options, our overview of weight loss injections explains how they compare.

Is Semaglutide a Peptide? Is Ozempic?

Yes. Semaglutide, the active ingredient in Ozempic and Wegovy, is a modified version of the human GLP-1 peptide. The Wegovy label describes it as a GLP-1 analog with "94% sequence homology to human GLP-1." Novo Nordisk researchers changed two amino acids and attached a fatty acid at position 26, so semaglutide binds to albumin, resists breakdown and lasts about a week (J Med Chem, 2015).

So Ozempic and Wegovy are peptide medicines, and so are Zepbound and Mounjaro. They are different peptides, though. Semaglutide activates the GLP-1 receptor only, while tirzepatide activates both the GIP and GLP-1 receptors. Our comparison of tirzepatide vs. Ozempic covers the differences in results, doses and cost.

Is GLP-1 a peptide?

Yes. GLP-1 stands for glucagon-like peptide-1, a hormone made in the intestine. People also use "GLP-1" as shorthand for the drugs built to act like it, the GLP-1 receptor agonists. The GLP-1 injections used for weight loss, including Wegovy and Zepbound, are peptides.

"Peptide" is a chemical category, not a type of treatment. GLP-1 medicines are one group of peptides. Calling a product "a peptide" tells you nothing about whether it's approved, what's really in the vial or whether it's safe to inject.

Is "semaglutide peptide" the same as Ozempic?

No. Semaglutide sold as a "research peptide" is not Ozempic or Wegovy. Compounded semaglutide isn't either: it is prepared by a licensed pharmacy for one patient's prescription and is not FDA-approved. The FDA has also warned that some semaglutide products sold by compounders may be salt forms, such as semaglutide sodium or semaglutide acetate, which it calls "different active ingredients than are used in the approved drugs" with no known lawful basis for use in compounding. Read more in our guide to semaglutide vs. Ozempic, or see how compounded semaglutide is prescribed at MaxLife.

What Is a "Tirzepatide Peptide" Sold Online?

A "tirzepatide peptide" sold online is usually a product labeled "for research purposes," "research use only" or "not for human consumption," sold without a prescription. These products are often powders that, in the FDA's words, are "intended for injection and require reconstitution."

The labels say these products aren't meant for people. The FDA says that claim is false. On its page about unapproved GLP-1 drugs (content current as of October 1, 2026), the agency says it has warned companies that illegally sold drugs containing semaglutide, tirzepatide, retatrutide and similar ingredients "that are falsely labeled 'for research purposes' or 'not for human consumption.'" It adds: "These products have been sold directly to consumers for human use with dosing instructions."

The FDA's warning letters show how it reads those labels:

• December 2024: the FDA posted four warning letters to companies selling unapproved semaglutide, tirzepatide or retatrutide products.
• February 2025: a letter to an online seller said that despite labels such as "research use only," "not for human consumption" and "lab purposes only," its products were "drugs intended for human use."
• March 2026: a letter about tirzepatide and retatrutide sold for "Research Use Only" said the evidence "establishes that your products are intended to be drugs for human use." Selling bacteriostatic water alongside the vials showed they were meant "to be used in combination for injection."
• August 2026: the FDA sent several more letters about tirzepatide, semaglutide and retatrutide sold this way. One pointed to a "peptide guide" and "peptide calculator" offered with the vials as the means "to prepare an injectable drug for human administration."

In each case, the FDA concluded that the products are unapproved new drugs and that selling them across state lines violates federal drug law.

Is It Safe or Legal to Buy Research Peptides for Weight Loss?

No. Research-use tirzepatide is not a safe or legal way to get treatment. The FDA treats these products as unapproved new drugs, says they "are of unknown quality and may be harmful to their health," and urges consumers not to buy them. Here is what the FDA says can go wrong:

• You don't know what's in the vial. Illegally sold GLP-1 drugs "may be counterfeit," "could contain the wrong ingredients or harmful ingredients" and "could contain too little, too much or no active ingredient at all."
• Injections skip some of your body's defenses. In a March 2026 warning letter, the FDA wrote that injectable products "bypass some of the body's key defenses against toxins and microorganisms that can lead to serious and life-threatening conditions."
• No one is responsible for your care. There is no prescriber who reviewed your health history and no pharmacist who prepared the product for you. The FDA's advice is to "obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy."
• Dosing is guesswork. A research vial comes with no prescriber's directions. Even with pharmacy-dispensed GLP-1s, the FDA has received reports of dosing errors, some requiring hospitalization, which is why it tells patients to ask their provider or pharmacy how to measure each dose.
• Some "peptides" sold next to tirzepatide aren't approved at all. Retatrutide "cannot be used in compounding under federal law" and has "not been found safe and effective for any condition," according to the FDA.

A "research only" label doesn't make a product legal to sell for human use; the FDA looks at how it is actually marketed. The difference between a prescription and a research vial comes down to accountability:

What Are the Legal Ways to Get Tirzepatide?

There are two legal ways to get tirzepatide in the U.S., and both start with a prescription from a licensed provider.

1. Brand Zepbound or Mounjaro. These are the FDA-approved tirzepatide medicines. Zepbound is approved for chronic weight management and for moderate to severe obstructive sleep apnea in adults with obesity; Mounjaro is approved for type 2 diabetes. Insurance coverage can bring the cost down a lot. Without coverage, LillyDirect lists Zepbound vials and KwikPens at $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg to 15 mg when you refill within 45 days, as of November 2026. Our guide to tirzepatide cost compares every route, with and without insurance.
2. Compounded tirzepatide from a state-licensed pharmacy. A licensed provider writes the prescription and a licensed pharmacy prepares it for you. Compounded tirzepatide is not FDA-approved, which means the FDA hasn't reviewed it for safety, effectiveness or quality. The FDA says compounded drugs should only be used when a patient's medical needs can't be met by an FDA-approved drug. Since the tirzepatide shortage ended on December 19, 2024, pharmacies may not regularly make what the FDA calls "essentially a copy" of an approved drug, unless a prescriber documents a significant difference for the individual patient (FDA, April 2026). The results of the Zepbound and Mounjaro trials have not been shown for compounded tirzepatide. Our guide to tirzepatide vs. Zepbound explains how compounded and brand tirzepatide differ.

How to tell a prescription from a research vial

The FDA's BeSafeRx checklist says a safe online pharmacy always requires a prescription, has a U.S. address and phone number, has a licensed pharmacist to answer your questions and is licensed by a state board of pharmacy. A dispensed vial carries a prescription label with your name, the pharmacy's name, the medicine, its strength and directions. A research vial has none of that.

The FDA also lists red flags for online programs, including prices "that seem too good to be true" and any company that "does not require a screening and prescription by a licensed doctor before providing medicine." Our guide to the best tirzepatide providers compares 24 online programs by real cost and shows what to check before you sign up.

How MaxLife Works

MaxLife offers the licensed route to compounded tirzepatide at a flat monthly price. MaxLife is a telehealth patient management platform, not a pharmacy or drug maker. You complete an online intake that takes about 2 minutes. An independent licensed provider reviews it, usually within 24 hours, and decides whether a prescription is right for you, and you can ask for a video visit. If you are prescribed compounded tirzepatide, a licensed partner pharmacy prepares and dispenses it with a patient-specific label and free expedited shipping, with supplies included.

Compounded tirzepatide through MaxLife costs $120 a month, flat, with no membership fee. Compounded semaglutide is $89 a month, flat. Both prices are all-inclusive and the same at every dose, with the provider's review and follow-up and the medicine if prescribed. No insurance is needed, HSA and FSA funds may be eligible, and MaxLife is LegitScript certified and available in all 50 states. To compare prices across programs, see the cheapest ways to get tirzepatide online.

Compounded tirzepatide isn't the right choice for everyone. If your insurance covers Zepbound or Mounjaro, the FDA-approved brand is usually the better route. Compounded medicines are not FDA-approved, and no compounded product has been shown to produce the results seen in the brand trials. What it does offer, unlike a research vial, is a licensed provider, a licensed pharmacy and a label with your name on it.

On February 20, 2026, the FDA sent MaxLife Warning Letter 721453 about statements on its website. MaxLife responded on February 24, 2026, revised its website and publishes its response and corrective actions.